NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

NVO

Novo Nordisk ADR

May 22 • 04:00PM ET

68.17

Dollar change -0.03
Percentage change -0.04	%

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: AVDE PPH DFIC APIE OZEM WINN PID RVER DFAI DFAX

Scroll to Statements

Index	-	P/E	20.22	EPS (ttm)	3.37	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	3.05%
Market Cap	229.47B	Forward P/E	14.47	EPS next Y	4.71	Insider Trans	-	Shs Float	3.37B	Perf Month	11.21%
Income	15.05B	PEG	1.06	EPS next Q	0.91	Inst Own	9.73%	Short Float	0.75%	Perf Quarter	-22.60%
Sales	43.59B	P/S	5.26	EPS this Y	25.94%	Inst Trans	-3.35%	Short Ratio	2.61	Perf Half Y	-31.70%
Book/sh	4.52	P/B	15.09	EPS next Y	18.36%	ROA	26.37%	Short Interest	25.12M	Perf Year	-48.71%
Cash/sh	1.79	P/C	38.14	EPS next 5Y	19.06%	ROE	87.53%	52W Range	57.00 - 148.15	Perf YTD	-20.75%
Dividend Est.	1.95 (2.86%)	P/FCF	16.06	EPS past 5Y	21.74%	ROI	44.25%	52W High	-53.99%	Beta	0.65
Dividend TTM	1.66 (2.43%)	Quick Ratio	0.56	Sales past 5Y	18.58%	Gross Margin	84.33%	52W Low	19.60%	ATR (14)	2.70
Dividend Ex-Date	Mar 31, 2025	Current Ratio	0.74	EPS Y/Y TTM	16.36%	Oper. Margin	45.11%	RSI (14)	53.79	Volatility	1.92% 2.76%
Employees	76302	Debt/Eq	0.86	Sales Y/Y TTM	22.74%	Profit Margin	34.52%	Recom	2.06	Target Price	99.34
Option/Short	Yes / Yes	LT Debt/Eq	0.70	EPS Q/Q	10.76%	Payout	35.93%	Rel Volume	0.74	Prev Close	68.20
Sales Surprise	1.73%	EPS Surprise	8.78%	Sales Q/Q	15.81%	Earnings	May 07 BMO	Avg Volume	9.62M	Price	68.17
SMA20	2.95%	SMA50	0.88%	SMA200	-29.82%	Trades		Volume	7,192,332	Change	-0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120
Oct-02-23	Initiated	Argus	Buy	$110
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-15-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-28-22	Downgrade	UBS	Neutral → Sell
Jun-27-22	Upgrade	Exane BNP Paribas	Underperform → Neutral
Jun-07-22	Upgrade	JP Morgan	Neutral → Overweight
May-31-22	Upgrade	Guggenheim	Neutral → Buy
Apr-25-22	Upgrade	Cowen	Market Perform → Outperform	$130
Apr-12-22	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Mar-16-22	Upgrade	Deutsche Bank	Hold → Buy

Show Previous Ratings

Today 07:45AM	Analysts Think These Stocks Could More Than Double in Value (MarketBeat)
May-22-25 01:16PM	Bitcoin soars, Fannie Mae & Freddie Mac, Novo's GLP-1 discount (Yahoo Finance Video)
10:01AM	Novo Nordisk battles Wegovy copycats through discounted prices, legal threats (Yahoo Finance)
08:00AM	New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy as federal ban on mass compounding of "semaglutide" takes effect (PR Newswire)
08:00AM	Did Eli Lilly Just Say Checkmate to Novo Nordisk? (Motley Fool)
07:56AM	Loading…
07:56AM	Wegovy and Zepbound costs capped at $200 in new Evernorth programme (Pharmaceutical Technology)
07:14AM	Evernorth reaches deals with Novo Nordisk, Eli Lilly to cap GLP-1 copays (Healthcare Dive)
06:56AM	Novo pressures GLP-1 compounders as FDA ban takes hold (BioPharma Dive)
06:39AM	Novo Nordisk's former chief makes comeback to steer choice of new CEO (Reuters)
04:00AM	Turning the page: Novos CEO transition reflects Big Pharmas era of change (Pharma Voice)
May-21-25 10:00AM	5 Single-Stock ETFs That Doubled in a Month (Zacks)
09:05AM	AstraZeneca Stock Declines 6% in 3 Months: Time to Buy the Dip? (Zacks)
08:50AM	AMGN Down 10% in 3 Months: How to Play the Stock as Tariff Woes Linger (Zacks)
04:22AM	BMO Capital Maintains Cautious Outlook on Novo Nordisk Amid CEO Transition (Insider Monkey)
May-20-25 01:49PM	Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race (Insider Monkey)
01:13PM	Loading…
01:13PM	Noom is offering smaller doses of compounded Wegovy for weight loss (Quartz)
01:13PM	Noom is offering microdoses of compounded Wegovy for weight loss (Quartz)
12:40PM	Why Novo Nordisk Stock Popped on Tuesday (Motley Fool)
11:00AM	Novo Nordisk Woes Just Hit Denmarks Economy. The Stock Is Rising. (Barrons.com)
10:53AM	2 Fantastic Beaten-Down Growth Stocks Down 40% and 45% to Buy (Motley Fool)
10:08AM	Novo Nordisk Woes Weigh on Denmarks Economy. Heres How. (Barrons.com)
09:13AM	What Makes Novo Nordisk (NVO) a Lucrative Investment? (Insider Monkey)
07:33AM	From Retina Scans to Cancer Trials, AI Is Taking Over the Exam Room (PR Newswire)
06:03AM	Weight-loss company Noom pivots to smaller doses of compounded Wegovy (Reuters)
May-19-25 11:04AM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
10:15AM	Novo Nordisk Shares Dip 3% on Sudden CEO Transition Announcement (Zacks)
09:51AM	The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie (Zacks)
08:29AM	PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now? (Zacks)
08:22AM	Novo Nordisk (NVO) Slides After CEO Departure; Analyst Flags Deeper Strategic Concerns (GuruFocus.com)
07:23AM	Novo Nordisks CEO to step down as weight loss market share plummets (Pharmaceutical Technology)
12:06PM	Loading…
May-17-25 12:06PM	Charter to combine with Cox, Take-Two reports mixed Q4 results: Morning Buzz (TipRanks)
07:00AM	MarketBeat Week in Review - 05/12 - 05/16 (MarketBeat)
May-16-25 10:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
07:18PM	Novo Nordisk should be thinking about 'what's next,' says Dr. Kavita Patel (CNBC TV)
04:30PM	Can a new CEO fix Novo Nordisk's problems? This analyst says no. (Yahoo Finance Video)
03:49PM	Analysis-Novo Nordisk should look to the US for its next CEO, analysts say (Reuters)
03:10PM	Novo Nordisk announces CEO transition as share price slips (FastCompany)
02:17PM	From insulin to Ozempic, history of Novo Nordisk's CEOs (Reuters)
02:05PM	Novo Nordisk CEO Exit After Massive Sell-Off Hits Shares (GuruFocus.com)
01:17PM	BMO's Evan David Seigerman: Novo Nordisk CEO departure reflects disparity with Eli Lilly (CNBC TV)
01:13PM	Galaxy Digital on the Nasdaq, Novo ousts CEO, Virgin Galactic (Yahoo Finance Video)
12:30PM	Stocks to Watch Friday: Charter, Novo Nordisk, Applied Materials (The Wall Street Journal)
11:52AM	Top Stock Movers Now: Charter Communications, Vistra, Cava Group, and More (Investopedia)
11:16AM	Novo Nordisk CEO to step down, citing market challenges (CNBC TV)
11:07AM	Why Novo Nordisk Stock Just Slipped (Motley Fool)
11:00AM	Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price (Investor's Business Daily)
10:45AM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
10:27AM	Novo Nordisk Boots CEO After Stock Falls 50%. Its an Unusual Move for the Wegovy Drugmaker. (Barrons.com)
09:58AM	Ozempic boss sacked after falling behind in weight-loss race (The Telegraph)
09:49AM	Novo Nordisk, Charter & Cox, Take Two: Trending Tickers (Yahoo Finance Video)
09:32AM	Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year (Quartz)
09:07AM	Novo Nordisk Stock Gains 14% in a Month: What Should Investors Do? (Zacks)
08:57AM	CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop (Associated Press Finance)
08:49AM	Novo Nordisk CEO steps down in surprise move as 'market challenges' weigh on obesity drugmaker (Yahoo Finance)
08:21AM	Instant View: Novo Nordisk CEO's surprise exit after setbacks in weight-loss market (Reuters)
08:17AM	Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price (CNBC TV)
08:15AM	5 Things to Know Before the Stock Market Opens (Investopedia)
08:12AM	Novo Nordisk Says CEO to Step Down Amid Stock Slump. The Shares Are Down 5%. (Barrons.com)
08:06AM	Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals (Zacks)
07:56AM	Here's Why Polen Focus Growth Strategy Exited Novo Nordisk A/S (NVO) (Insider Monkey)
07:48AM	Is Small-Cap Corbus Pharma a Worthy Cannabis Investment? (Zacks)
07:45AM	Novo Nordisk Stock Falls on Surprise CEO Departure (Investopedia)
07:30AM	Novo Nordisk's Ozempic Weight Loss Jabs Could Boost UK Economy By $6 Billion, Study Finds (Benzinga)
07:19AM	Novo Nordisk A/S: Lars Fruergaard Jørgensen to step down as CEO of Novo Nordisk (GlobeNewswire)
07:06AM	Obesity drug maker Novo Nordisk ousts CEO as competition weighs (Reuters)
04:47AM	Wall Street Expects This Obesity Drug Stock to Skyrocket 35% Over the Next 12 Months (Motley Fool)
May-15-25 10:00AM	ETFs to Capitalize on the Novo Nordisk-Septerna Deal (Zacks)
09:00AM	Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now? (Zacks)
08:46AM	Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk (Zacks)
07:45AM	Is It Time to Buy the Dip in Novo Nordisk Stock? (MarketBeat)
May-14-25 05:20PM	Eli Lilly Shares Tumble After Rival Novo?Nordisk Strikes Major Weight Loss Deal (GuruFocus.com)
04:26PM	Stock Market Today: Dow Jones Slips As Nvidia Takes Apple's Crown; AMD Shoots Higher (Live Coverage) (Investor's Business Daily)
04:06PM	Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna Skyrocketing (Investor's Business Daily)
02:22PM	eToro's Nasdaq debut, Exelixis outlook, SepternaNovo deal (Yahoo Finance Video)
01:29PM	Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies (Pharmaceutical Technology)
11:59AM	Healthcare worst-performing S&P subsector YTD: Mizuho expert (Yahoo Finance)
11:59AM	Healthcare worst-performing S&P 500 subsector year to date: Mizuho expert (Yahoo Finance)
11:08AM	Stock Market Today: Dow Wavers As Nvidia Seizes Apple's Crown, CoreWeave Jumps As Earnings Loom (Live Coverage) (Investor's Business Daily)
11:08AM	Stock Market Today: Dow Dips As Nvidia Eyes Apple's Crown; Tesla Extends Gains As Super Micro Soars (Live Coverage) (Investor's Business Daily)
10:28AM	Novo Nordisk Rises on Weight-Loss News. Its a Huge Deal for This Stock. (Barrons.com)
09:35AM	Novo Nordisk, Septerna sign $2.2B deal to develop weight-loss pill (Yahoo Finance Video)
09:32AM	Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna (Yahoo Finance)
09:32AM	Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Sapterna (Yahoo Finance)
08:51AM	Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock? (Zacks)
07:03AM	Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments (Reuters)
06:59AM	Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases (GlobeNewswire)
04:01AM	Why Novo Nordisk (NVO) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom (Insider Monkey)
03:18AM	Lexicon Pharmaceuticals Inc (LXRX) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ... (GuruFocus.com)
May-13-25 07:08PM	Why Weight-Loss Developer Stocks Tumbled on Tuesday (Motley Fool)
10:46AM	Novo Nordisk A/S (NVO): A Bull Case Theory (Insider Monkey)
08:46AM	How Hims & Hers survived the great Spac shakeout (Financial Times)
May-12-25 07:20PM	Trump's drug price order is part request, part threat: Analyst (Yahoo Finance Video)
04:57PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
04:25PM	S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite' (Investor's Business Daily)
04:09PM	Trump calls out weight-loss drugs as target of price-cut push (Reuters)
03:50PM	How Trump could go about executing order to slash drug prices (Yahoo Finance Video)
02:35PM	Global Pharma Stocks Rebound as Investors See Hurdles in Trump Drug Plan (Investopedia)
12:45PM	Novo Nordisks Sogroya matches Norditropin in childrens growth disorders (Clinical Trials Arena)
12:14PM	Fox One, SoftBank delays investment, Zepbound weight loss (Yahoo Finance Video)
12:07PM	Big News! U.S. and China Trade Deal Shakes Up Markets (Motley Fool)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience